ConductScience.org, home

Paper4334089

1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.

Wilson CB and 2 others. Cancer Chemother Rep, 1970. Cited by 172 papers, by iCite.

Cite this record

ConductScience Library. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors. Papers, record 4334089. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4334089

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
PubMed
Journal
Cancer Chemother Rep
PubMed
Year
1970
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
172
iCite
Relative citation ratio, by iCite
6.28
iCite
Revised in PubMed
2016-06-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilson CBC B
2Boldrey EBE B
3Enot KJK J

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
AstrocytomaMajor topic
Brain NeoplasmsMajor topic
GlioblastomaMajor topic
Nitroso CompoundsMajor topic
UreaMajor topic
Adenocarcinoma
Adolescent
Chordoma
Clinical Trials as Topic
Ependymoma
Glioma
Humans
Hyperemia
Male
Medulloblastoma
Melanoma
Middle Aged
Nausea
Nitrosourea Compounds
Phlebitis
Radiotherapy
Vomiting

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 172 citations.

PMIDTitleJournalYearIn PapersSource
35446393Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.J Neuropathol Exp Neurol2022https://conductscience.org/library/papers/35446393PubMed
34944933Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age.Cancers (Basel)2021https://conductscience.org/library/papers/34944933PubMed
19344302Design and application of oncolytic HSV vectors for glioblastoma therapy.Expert Rev Neurother2009https://conductscience.org/library/papers/19344302PubMed
18813876What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma.J Neurooncol2009https://conductscience.org/library/papers/18813876PubMed
12777076Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015.J Neurooncol2003https://conductscience.org/library/papers/12777076PubMed
10780513Chemotherapy for high-grade gliomas.Br J Cancer2000https://conductscience.org/library/papers/10780513PubMed
7807189The basis for current treatment recommendations for malignant gliomas.J Neurooncol1994https://conductscience.org/library/papers/7807189PubMed
6678305A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.J Neurooncol1983https://conductscience.org/library/papers/6678305PubMed
6289164Measurements of the volume and density of intracerebral tumors by CT following therapy.Neuroradiology1982https://conductscience.org/library/papers/6289164PubMed
6088725Treatment of malignant gliomas in adults with BCNU plus metronidazole.J Neurooncol1984https://conductscience.org/library/papers/6088725PubMed
6088718High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas.J Neurooncol1983https://conductscience.org/library/papers/6088718PubMed
4085418Repair of O6-(2-chloroethyl)guanine mediates the biological effects of chloroethylnitrosoureas.Environ Health Perspect1985https://conductscience.org/library/papers/4085418PubMed
4056852Pharmacokinetics of 11C-BCNU in experimental brain tumor.J Neurooncol1985https://conductscience.org/library/papers/4056852PubMed
3903064Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors.J Neurooncol1985https://conductscience.org/library/papers/3903064PubMed
2937887Phase I clinical trial of intracarotid bis-chloroethylnitrosourea (BCNU) and 2' dioxy-5-fluorouridine (FUDR) in malignant astrocytomas.J Neurooncol1986https://conductscience.org/library/papers/2937887PubMed
2358844Chemosensitivity testing of human gliomas using a fluorescent microcarrier technique.J Neurooncol1990https://conductscience.org/library/papers/2358844PubMed
2319289Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.J Neurooncol1990https://conductscience.org/library/papers/2319289PubMed
1848735Brain tumors.West J Med1991https://conductscience.org/library/papers/1848735PubMed
1744686Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.J Neurooncol1991https://conductscience.org/library/papers/1744686PubMed
1643694Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomas.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1643694PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4334089

GET https://conductscience.org/api/papers/v1/4334089/cited_by?page=2